Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24994860.
- Also identified by DOI 10.1136/archdischild-2013-304822.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The term Ehlers-Danlos syndrome (EDS) encompasses a group of inherited connective tissue disorders. The manifestations of EDS can be seen in skin, joints, blood vessels and internal organs and vary from mild to severe and life threatening. Each subtype is a separate and different condition. The genetic basis of many subtypes has now been elucidated, confirming heterogeneity. An awareness of the different conditions within this group is the starting point towards accurate diagnosis. Accurate elicitation of history and clinical signs is vital in selecting the correct confirmatory investigation. Skin biopsy with electron microscopy can be helpful in the decision process of whether and when to perform genetic testing. Correct diagnosis within the EDSs allows targeted management, family screening and prenatal diagnosis.
Medical subject headings
- Ehlers-Danlos Syndrome
- Ehlers-Danlos Syndrome/classification
- Ehlers-Danlos Syndrome/diagnosis
- Ehlers-Danlos Syndrome/genetics
- Genetic Testing
- Humans